The role of glycogen synthase kinase-3β in glioma cell apoptosis induced by remifentanil

The aim of malignant glioma treatment is to inhibit tumor cell proliferation and induce tumor cell apoptosis. Remifentanil is a clinical anesthetic drug that can activate the N-methyl-D-aspartate (NMDA) receptor. NMDA receptor signaling activates glycogen synthase kinase-3β (GSK-3β). Discovered some...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jing, Xu, Pengjuan, Li, Zhigui, Xiao, Lu, Yang, Zhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2013
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275801/
https://www.ncbi.nlm.nih.gov/pubmed/23990403
http://dx.doi.org/10.2478/s11658-013-0102-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275801/
https://www.ncbi.nlm.nih.gov/pubmed/23990403
http://dx.doi.org/10.2478/s11658-013-0102-3

Ejemplares similares